Micro-RNA may amplify effectiveness of sorafenib in difficult liver cancer cases – Science Daily

Micro-RNA may amplify effectiveness of sorafenib in difficult liver cancer cases
Science Daily
Antonio Giordano, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia. "Sorafenib is still the only drug indicated in the treatment of hepatocellular carcinoma, which highlights the ...

View post:

Micro-RNA may amplify effectiveness of sorafenib in difficult liver cancer cases - Science Daily

Related Posts

Comments are closed.